DrugPatentWatch Database Preview
ENBREL Drug Profile
» See Plans and Pricing
Summary for Tradename: ENBREL
| Patents: | 378 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
| Drug Prices: | Drug price information for ENBREL |
| Recent Clinical Trials: | See clinical trials for ENBREL |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ENBREL |
Recent Clinical Trials for ENBREL
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Sorrento Therapeutics, Inc. | Phase 1 |
| Nova Southeastern University | Phase 1 |
| Rochester General Hospital | Phase 1 |
Recent Litigation for ENBREL
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Pharmacyclics LLC v. Alvogen Pine Brook, LLC | 2020-03-20 |
| Celgene Corporation v. Mylan Pharmaceuticals Inc. | 2020-01-02 |
| CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. | 2019-12-30 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Dr. Reddy's Laboratories, Inc. | 2018-08-03 |
| 2014-11-06 | |
| 2013-08-15 |
Pharmacology for ENBREL
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
Company Disclosures: US Patents for ENBREL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2012-03-07 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2014-02-25 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2009-09-05 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2009-09-11 | RX | Orphan | company |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | 2009-09-05 | RX | Orphan | company | |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Immunex Corporation (Seattle, WA) | 2009-09-05 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for ENBREL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Massachusetts Eye and Ear Infirmary (Boston, MA) | 2034-06-16 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Knopp Biosciences LLC (Pittsburgh, PA) | 2033-08-13 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | Coherus Biosciences, Inc. (Redwood City, CA) | 2039-02-26 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | LUPIN LIMITED (Mumbai, Maharashtra, IN) | 2032-10-26 | RX | Orphan | search |
| Immunex | ENBREL | etanercept | VIAL; SUBCUTANEOUS | 103795 | 001 | 1998-11-02 | Get Started for $10 | The William M. Yarbrough foundation (Peoria, IL) | 2032-07-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ENBREL
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2016200361 | Get Started for $10 |
| Eurasian Patent Organization | 201170396 | Get Started for $10 |
| Australia | 2011332810 | Get Started for $10 |
| Canada | 2889271 | Get Started for $10 |
| Eurasian Patent Organization | 200700813 | Get Started for $10 |
| China | 101779178 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ENBREL
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 1090038-9 | Sweden | Get Started for $10 | PRODUCT NAME: DENOSUMAB |
| 591 | Finland | Get Started for $10 | |
| PA2017038,C2041177 | Lithuania | Get Started for $10 | PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623 |
| C300008 | Netherlands | Get Started for $10 | PRODUCT: ETANERCEPTUM |
| C 2015 016 | Romania | Get Started for $10 | PRODUCT NAME: IBRUTINIB SAU O SARE FARMACEUTIC ACCEPTABILA A ACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/14/945; DATE OF NATIONAL AUTHORISATION: 20141021; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/945; DATE OF FIRST AUTHORISATION IN EEA: 20141021 |
| 2090010-6 | Sweden | Get Started for $10 | PRODUCT NAME: UPADACITINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/19/1404 20191218 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
